Literature DB >> 20594817

Utility of high-resolution computed tomography and BAL in cryptogenic organizing pneumonia.

L Jara-Palomares1, L Gomez-Izquierdo, D Gonzalez-Vergara, E Rodriguez-Becerra, E Marquez-Martin, E Barrot-Cortés, J Martin-Juan.   

Abstract

BACKGROUND: Cryptogenic organizing pneumonia (COP) is a rare disease, and its diagnosis requires histological confirmation. The objective of our study was to describe the findings of the thoracic high-resolution computed tomography (HR-CT) and bronchoalveolar lavage (BAL) in patients with confirmed COP and evaluate the complementary diagnostic use of BAL and thoracic HR-CT.
METHODS: Patients recorded in the registry of interstitial pulmonary diseases between 1991 and 2008 were located and the COP patients selected.
RESULTS: We identified 21 patients with histological confirmation of COP. The median age was 58.0 ± 15.9 years, and 61.9% of patients were female. The most frequent thoracic HR-CT profile was patchy infiltrate (71.4%), followed by parenchymatous consolidation (42.9%). The most frequent BAL profile was mixed alveolitis (62%) with lymphocyte predominance, a CD4/CD8 index of 0.4 and foamy macrophages. The effectiveness of transbronchial biopsy was 66.6%. The diagnostic utility of Poletti's BAL criteria gives us a specificity of 88.8%, although the sensitivity obtained was low. The specificity of certain HR-CT profiles is 99%. In addition, we observed a complementary use of the HR-CT and the BAL.
CONCLUSIONS: The imaging findings and BAL could be useful for patients with appropriate clinical presentation and for those whose transbronchial biopsy is negative or for whom a confirmatory biopsy cannot be performed.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20594817     DOI: 10.1016/j.rmed.2010.06.008

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Lesion with morphologic feature of organizing pneumonia (OP) in CT-guided lung biopsy samples for diagnosis of bronchiolitis obliterans organizing pneumonia (BOOP): a retrospective study of 134 cases in a single center.

Authors:  Liyun Miao; Yongsheng Wang; Yan Li; Jingjing Ding; Lulu Chen; Jinghong Dai; Hourong Cai; Yonglong Xiao; Min Cao; Mei Huang; Yuying Qiu; Fanqing Meng; Xiangshan Fan; Deping Zhang; Yong Song
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

2.  'Crazy-paving' pattern: an exceptional presentation of cryptogenic organising pneumonia associated with chronic obstructive pulmonary disease.

Authors:  Shekhar Kunal; Vikas Pilaniya; Sudhir Jain; Ashok Shah
Journal:  BMJ Case Rep       Date:  2016-05-06

Review 3.  Micronodular pattern of organizing pneumonia: Case report and systematic literature review.

Authors:  François Lebargy; Davy Picard; Jean Hagenburg; Olivier Toubas; Jeanne-Marie Perotin; Sebastian Sandu; Gaëtan Deslee; Sandra Dury
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

4.  CT patterns of organizing pneumonia in patients treated with VEGF/mTOR inhibitors for metastatic renal cell cancer: an observational study.

Authors:  Sabine Dettmer; Viktor Grünwald; Thomas Fuehner; Arnold Ganser; Frank Wacker; Philipp Ivanyi; Thomas Rodt
Journal:  Acta Radiol Open       Date:  2017-02-01

5.  Cryptogenic Organizing Pneumonia: Evolution of Morphological Patterns Assessed by HRCT.

Authors:  Francesco Tiralongo; Monica Palermo; Giulio Distefano; Ada Vancheri; Gianluca Sambataro; Sebastiano Emanuele Torrisi; Federica Galioto; Agata Ferlito; Giulia Fazio; Pietro Valerio Foti; Letizia Antonella Mauro; Carlo Vancheri; Stefano Palmucci; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2020-04-29

6.  Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma.

Authors:  Sabino Strippoli; Livia Fucci; Antonio Negri; Daniela Putignano; Marco Luigi Cisternino; Gaetano Napoli; Ruggiero Filannino; Ivana De Risi; Angela Monica Sciacovelli; Michele Guida
Journal:  J Transl Med       Date:  2020-12-10       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.